Abstract:Background: The staging of primary lower extremity lymphedema (LEL) is difficult yet vital in clinical work, and magnetic resonance imaging (MRI) can be used for quantitative assessment of primary LEL due to its high resolution for soft tissues. In this study, we evaluated the value of MRI-based soft tissue area measurements for staging primary LEL.Methods: A total of 90 consecutive patients with clinically diagnosed primary lower limb lymphoedema from January 2017 to December 2019 in Beijing Shijitan Hospital were enrolled retrospectively. Short time inversion recovery (STIR) sequence was applied to measure the total, muscle, bone, and subcutaneous areas in the upper 1/3 level of the bilateral lower calf. The difference between the affected and unaffected calf regarding the subcutaneous area was obtained, and (subcutaneous area)/(bone area) and (subcutaneous area)/ (muscle area) were calculated. According to the International Society of Lymphology (ISL) clinical staging standard established in 2020, all patients were divided into stages I, II, and III, accordingly. Statistical analysis was performed to determine the validity of MRI measurements in staging LEL.Results: There were 33 patients classified as stage I clinically, 44 patients as stage II, and 13 patients as stage III. There were significant differences in total, subcutaneous, the difference in subcutaneous area of limbs, subcutaneous/bone (S/B), and subcutaneous/muscle (S/M) between stage I and II as well as between stage I and III (P<0.001), but not between stage II and III (P=0.706, 0.329, and 0.229, respectively). A positive correlation was detected between the clinical stage and difference in subcutaneous area of limbs (rho =0.752, P<0.001), S/B (rho =0.747, P<0.001), S/M (rho =0.709, P<0.001), and subcutaneous (rho =0.723, P<0.001). For staging primary LEL, receiver operating characteristic (ROC) curves indicated that the difference in subcutaneous area of limbs had the best discrimination ability among parameters [area under the ROC curve (AUC) =0.950; 95% confidence interval (CI): 0.875-0.987; sensitivity: 95.45%; specificity: 84.85%], followed by S/B (AUC =0.930; 95% CI: 0.848-0.975; sensitivity: 77.27%; specificity: 93.94%) and S/M (AUC =0.895; 95% CI: 0.804-0.953; sensitivity: 77.27%; specificity: 90.91%). The ROC curves indicated that subcutaneous area (AUC =0.927; 95% CI: 0.844-0.974; sensitivity: 84.09%, specificity: 90.91%) and total (AUC =0.852; 95% CI: 0.753-0.923; sensitivity: 70.45%; specificity: 90.91%) also had discrimination ability between stage I and II. Conclusions: The measurement of the soft tissue area of the calf may be used as an auxiliary method for staging primary LEL. For patients with unilateral primary LEL, the difference in subcutaneous area of limbs could be a specific indicator to distinguish clinical stage I from II.

99Tcm-Dx Imaging for Extremity Lymphedema

Contrast-enhanced ultrasound for the differential diagnosis between benign and metastatic superficial lymph nodes: a meta-analysis

Characterizing Normal Upper Extremity Lymphatic Flow with 99mTc In-House Dextran: A Retrospective Study

The added value of SPECT/CT lymphoscintigraphy in the initial assessment of secondary extremity lymphedema patients

Functional Evalution of Lymphatic Vessels of Low Extremity Lymphedema with 3.0 T Dynamic Enhanced MR Lymphangiography

Value of imaging examinations in treatment of lymphangioleiomyomatosis with chylothorax by thoracic duct extremity exploration

Semi-quantitative Analysis of EBUS Elastography as a Feasible Approach in Diagnosing Mediastinal and Hilar Lymph Nodes of Lung Cancer Patients

MRI Features of Primary Lower Extremity Lymphedema: a Retrospective Analysis of 228 Patients

Quantitative Evaluation of Primary Lower Extremity Lymphedema Staging Using MRI: a Preliminary Study

The Value of the Dermal Rim Sign on Nonenhanced MRI for Predicting Dermal Backflow in Patients with Primary Lower Extremity Lymphedema

Visualization of lower extremity lymphedema in the same cohort using 99mTc-human serum albumin and 99mTc-phytate lymphoscintigraphy with SPECT-CT

An Experimental Study on Interstitial MR Lymphography

Lower Limb Lipedema-Superficial Lymph Flow, Skin Water Concentration, Skin and Subcutaneous Tissue Elasticity

Scintigraphic differentiation of congenital soft-tissue extremity enlargement with Tc-99m DTPA

Investigating the Lymphatic System by Dual-Color Elemental Mass Spectrometry Imaging

MODIFIED LYMPHOSCINTIGRAPHY IN PRIMARY LYMPHATIC INSUFFICIENCY OF THE LOWER LIMB

Clinical Value of Real Time Elastography in Patients with Unexplained Cervical Lymphadenopathy: Quantitative Evaluation.

Lymphatic Plastic Bronchitis and Primary Chylothorax: A Study Based on Computed Tomography Lymphangiography

Three-dimensional non-contrast magnetic resonance lymphography severity stage for upper extremity lymphedema

Noninvasive, objective evaluation of lower extremity lymphedema severity using shear wave elastography: A preliminary study

The Experimental Study on Lymphography